Roger Sewell and Elisabeth Crowe analyse the agency’s new guidance and explain how device sponsors can benefit from using the Bayesian approach.
The US Food and Drug Administration has published the finalised version of its Guidance for the Use of Bayesian Statistics in Medical Device Clinical Trials, nearly four years after issuing the draft version for public comment1,2...
Please login to read the full article.
